METHODS AND DEVICES FOR PREDICTING ANTHRACYCLINE TREATMENT EFFICACY

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP15822898.1

公开号：

EP3169815A1

申请日:

2015.07.15

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

The invention features methods, devices, and kits for predicting the responsiveness of a cancer patient (e.g., a breast cancer patient, such as a grade 1, 2, or 3 breast cancer patient) to anthracycline treatment by determining the expression levels of four chromosomal instability (CIN) genes including HDGF, KIAA0286, RFC4, and MSH6, collectively referred to as CIN4. Patients that have a low CIN4 score benefit from anthracycline treatment compared patients with a high CIN4 score.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/